ArticleInternational immunology2019

Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis.

Takayoshi Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.